Free Trial
CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

Voyageur Pharmaceuticals logo
C$0.18 +0.01 (+2.94%)
As of 02:58 PM Eastern

About Voyageur Pharmaceuticals Stock (CVE:VM)

Key Stats

Today's Range
C$0.17
C$0.18
50-Day Range
C$0.16
C$0.34
52-Week Range
C$0.04
C$0.36
Volume
208,140 shs
Average Volume
203,257 shs
Market Capitalization
C$26.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VM Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
See More Headlines

VM Stock Analysis - Frequently Asked Questions

Voyageur Pharmaceuticals' stock was trading at C$0.09 on January 1st, 2025. Since then, VM shares have increased by 105.9% and is now trading at C$0.18.

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Voyageur Pharmaceuticals investors own include GFG Resources (GFG), Pine Cliff Energy (PNE), Tamarack Valley Energy (TVE), Caladrius Biosciences (CLBS), Capstone Copper (CS), Calibre Mining (CXB) and Mawson Gold (MAW).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:VM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$1.66 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-117.77%
Return on Assets
-30.77%

Debt

Debt-to-Equity Ratio
4.23
Current Ratio
0.10
Quick Ratio
0.84

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.01 per share
Price / Cash Flow
35.00
Book Value
C$0.01 per share
Price / Book
25.83

Miscellaneous

Outstanding Shares
151,517,550
Free Float
N/A
Market Cap
C$26.52 million
Optionable
Not Optionable
Beta
0.32
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:VM) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners